Toshio Hirano

Toshio Hirano (平野 俊夫, Hirano Toshio, born April 17, 1947 in Osaka, Japan) is a Japanese immunologist and academic, best known for his discovery of interleukin-6.[1][2] Since August 2011, he has served as the 17th President of Osaka University.

Toshio Hirano
Hirano in 2009
Born (1947-04-17) April 17, 1947
Nationality Japan
Alma materOsaka University
Known forDiscovery of interleukin-6 and its application in treating diseases
AwardsCrafoord Prize (2009)
Japan Prize (2011)
Scientific career
FieldsBioscience and Medical Science

Chronology

  • 1972 - graduated from Graduate School of Medicine, Osaka University[2]
  • 1980 - assistant professor in the School of Medicine, Kumamoto University[2]
  • 1984 - assistant professor at Institute for Molecular and Cellular Biology, Osaka University[2]
  • 1989 - professor at the same university[2]
  • 2004 - Dean of Graduate School of Frontier Biosciences, Osaka University[2]
  • 2008 - Dean of Graduate School of Medicine, Osaka University[2]
  • August 2011 - the 17th president of Osaka University[3]

Honors and awards

  • Erwin von Balz prize (Japan), 1986
  • CIBA-GEIGY Rheumatism Prize (Japan), 1990
  • Sandoz Prize for Immunology, 1992
  • Osaka Science Prize (Japan), 1997
  • Mochida Memorial Prize (Japan), 1998
  • ISI Citation Laureate Award (Japan), 198198, 2000
  • The Fujihara Award, 2004 The Fujiwara Foundation of Science
  • Medical Award of The Japan Medical Association, 2005, The Japan Medical Association
  • Medal of Honor with Purple Ribbon, April, 2006
  • The Crafoord Prize in Polyarthritis 2009
  • The Japan Prize for the discovery of interleukin-6, 2011

References

  1. "Curriculum Vitae". University of Osaka. Retrieved 2009-07-09.
  2. http://www.japanprize.jp/en/prize_prof_2011_hirano.html, the Japan Prize Foundation
  3. "Archived copy". Archived from the original on 2012-04-04. Retrieved 2011-11-25.CS1 maint: archived copy as title (link), Osaka University president profile


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.